{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:55:53Z","timestamp":1790776553165,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":577,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>The molecular mechanisms underlying the genesis of cholangiocarcinomas (CCs) are poorly understood. Epigenetic changes such as aberrant hypermethylation and subsequent atypical gene expression are characteristic features of most human cancers. In CC, data regarding global methylation changes are lacking so far. We performed a genome-wide analysis for aberrant promoter methylation in human CCs. We profiled 10 intrahepatic and 8 extrahepatic CCs in comparison to non-neoplastic biliary tissue specimens, using methyl-CpG immunoprecipitation (MCIp) combined with whole-genome CpG island arrays. DNA methylation was confirmed by quantitative mass spectrometric analysis and functional relevance of promoter hypermethylation was shown in demethylation experiments of two CC cell lines using 5-aza-2\u2032deoxycytidine (DAC) treatment. Immunohistochemical staining of tissue microarrays (TMAs) from 223 biliary tract cancers (BTCs) was used to analyze candidate gene expression at the protein level. Differentially methylated, promoter-associated regions were nonrandomly distributed and enriched for genes involved in cancer-related pathways including Wnt, transforming growth factor beta (TGF-\u03b2), and PI3K signaling pathways. In CC cell lines, silencing of genes involved in Wnt signaling, such as<\/jats:bold>\n                                 <jats:bold>\n                                    SOX17, WNT3A\n                                 <\/jats:bold>\n                                 <jats:bold>,<\/jats:bold>\n                                 <jats:bold>\n                                    DKK2\n                                 <\/jats:bold>\n                                 <jats:bold>,<\/jats:bold>\n                                 <jats:bold>\n                                    SFRP1, SFRP2\n                                 <\/jats:bold>\n                                 <jats:bold>, and<\/jats:bold>\n                                 <jats:bold>\n                                    SFRP4\n                                 <\/jats:bold>\n                                 <jats:bold>was reversed after DAC administration. Candidate protein SFRP2 was substantially down-regulated in neoplastic tissues of all BTC subtypes as compared to normal tissues. A significant inverse correlation of SFRP2 protein expression and pT status was found in BTC patients.<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion\n                                 <\/jats:bold>\n                                 <jats:bold>: We provide a comprehensive analysis to define the genome-wide methylation landscape of human CC. Several candidate genes of cancer-relevant signaling pathways were identified, and closer analysis of selected Wnt pathway genes confirmed the relevance of this pathway in CC. The presented global methylation data are the basis for future studies on epigenetic changes in cholangiocarcinogenesis. (Hepatology 2014;59:544\u2013554)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26721","type":"journal-article","created":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T17:28:36Z","timestamp":1378229316000},"page":"544-554","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":105,"title":["Global Alterations of DNA Methylation in Cholangiocarcinoma Target the Wnt Signaling Pathway"],"prefix":"10.1097","volume":"59","author":[{"given":"Benjamin","family":"Goeppert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Konermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Roman","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Bogatyrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Geiselhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Zucknick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianeb","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Hafezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Klauschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Stenzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Warth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Breuhahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilko","family":"Weichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schirmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Plass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Weichenhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20250207","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: thirtyoneyear experience with 564 patients at a single institution.","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann Surg"},{"key":"R3-22-20250207","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma.","volume":"8","author":"Blechacz","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R4-22-20250207","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1200\/JCO.2009.27.4787","article-title":"Genetics of biliary tract cancers and emerging targeted therapies.","volume":"28","author":"Hezel","year":"2010","journal-title":"J Clin Oncol"},{"key":"R5-22-20250207","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer.","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"key":"R6-22-20250207","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/hmg\/11.20.2479","article-title":"Cancer epigenomics.","volume":"11","author":"Plass","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R7-22-20250207","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jmg.38.5.285","article-title":"Methylation matters.","volume":"38","author":"Costello","year":"2001","journal-title":"J Med Genet"},{"key":"R8-22-20250207","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/modpathol.3800287","article-title":"Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma.","volume":"18","author":"Yang","year":"2005","journal-title":"Mod Pathol"},{"key":"R9-22-20250207","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.1478-3231.2005.01174.x","article-title":"Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.","volume":"25","author":"Foja","year":"2005","journal-title":"Liver Int"},{"key":"R10-22-20250207","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/path.1139","article-title":"Genetic and epigenetic alterations of the INK4aARF pathway in cholangiocarcinoma.","volume":"197","author":"Tannapfel","year":"2002","journal-title":"J Pathol"},{"key":"R11-22-20250207","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4291\/wjgp.v1.i2.23","article-title":"Aberrant DNA methylation profile in cholangiocarcinoma.","volume":"1","author":"Huang","year":"2010","journal-title":"World J Gastrointest Pathophysiol"},{"key":"R13-22-20250207","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics.","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol"},{"key":"R14-22-20250207","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/bioinformatics\/btm412","article-title":"A comparison of background correction methods for twocolour microarrays.","volume":"23","author":"Ritchie","year":"2007","journal-title":"Bioinformatics"},{"key":"R15-22-20250207","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/nar\/29.12.2549","article-title":"Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects.","volume":"29","author":"Tseng","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"R16-22-20250207","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer.","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"key":"R17-22-20250207","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1073\/pnas.0712251105","article-title":"Cytosine methylation profiling of cancer cell lines.","volume":"105","author":"Ehrich","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-22-20250207","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","article-title":"TM4: a free, opensource system for microarray data management and analysis.","volume":"34","author":"Saeed","year":"2003","journal-title":"Biotechniques"},{"key":"R19-22-20250207","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.","volume":"4","author":"da Huang","year":"2009","journal-title":"Nat Protoc"},{"key":"R20-22-20250207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists.","volume":"37","author":"da Huang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"R21-22-20250207","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1158\/0008-5472.CAN-12-2230","article-title":"1p36 tumor suppressiona matter of dosage?","volume":"72","author":"Henrich","year":"2012","journal-title":"Cancer Res"},{"key":"R22-22-20250207","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/bjc.2011.550","article-title":"Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research.","volume":"106","author":"Shenker","year":"2012","journal-title":"Br J Cancer"},{"key":"R23-22-20250207","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF02482735","article-title":"Aberrant methylation of genes in lowgrade astrocytomas.","volume":"17","author":"Costello","year":"2000","journal-title":"Brain Tumor Pathol"},{"key":"R24-22-20250207","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wntbetacatenin signaling and disease.","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"R25-22-20250207","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2407-11-78","article-title":"Genomewide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma.","volume":"11","author":"Seol","year":"2011","journal-title":"BMC Cancer"},{"key":"R26-22-20250207","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ng.2273","article-title":"Exome sequencing of liver flukeassociated cholangiocarcinoma.","volume":"44","author":"Ong","year":"2012","journal-title":"Nat Genet"},{"key":"R27-22-20250207","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1101\/sqb.2010.75.031","article-title":"Role of nuclear architecture in epigenetic alterations in cancer.","volume":"75","author":"Easwaran","year":"2010","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"R28-22-20250207","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2012.11.006","article-title":"Regional activation of the cancer genome by longrange epigenetic remodeling.","volume":"23","author":"Bert","year":"2013","journal-title":"Cancer Cell"},{"key":"R29-22-20250207","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.25870","article-title":"Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.","volume":"56","author":"Neumann","year":"2012","journal-title":"Hepatology"},{"key":"R30-22-20250207","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.510270412","article-title":"Expression of Ecadherin, alphacatenin, betacatenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.","volume":"27","author":"Ashida","year":"1998","journal-title":"Hepatology"},{"key":"R31-22-20250207","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.0106-9543.2001.01580.x","article-title":"The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of Ecadherin, alphacatenin and betacatenin.","volume":"22","author":"Asayama","year":"2002","journal-title":"Liver"},{"key":"R32-22-20250207","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/modpathol.3880409","article-title":"Altered expression of betacatenin without genetic mutation in intrahepatic cholangiocarcinoma.","volume":"14","author":"Sugimachi","year":"2001","journal-title":"Mod Pathol"},{"key":"R33-22-20250207","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ng1330","article-title":"Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer.","volume":"36","author":"Suzuki","year":"2004","journal-title":"Nat Genet"},{"key":"R34-22-20250207","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/0008-5472.CAN-05-3712","article-title":"CpG island methylation and expression of the secreted frizzledrelated protein gene family in chronic lymphocytic leukemia.","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res"},{"key":"R35-22-20250207","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1073\/pnas.94.7.2859","article-title":"A family of secreted proteins contains homology to the cysteinerich ligandbinding domain of frizzled receptors.","volume":"94","author":"Rattner","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R36-22-20250207","doi-asserted-by":"crossref","first-page":"a007989","DOI":"10.1101\/cshperspect.a007989","article-title":"Wnt signaling, stem cells, and cancer of the gastrointestinal tract.","volume":"4","author":"Schepers","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R37-22-20250207","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2012.06.008","article-title":"Cancer genetics and epigenetics: two sides of the same coin?","volume":"22","author":"You","year":"2012","journal-title":"Cancer Cell"},{"key":"R38-22-20250207","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome biological and translational implications.","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat Rev Cancer"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26721","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201402000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:51:28Z","timestamp":1738947088000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201402000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26721","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}